Repositioning Candidates
Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
Search for:
Pneumonia81 records.
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria | |
|---|---|---|---|---|---|---|
| R0023 | DB00080 | approved; investigational | small molecule | Daptomycin | Indication associated | Details |
| R0073 | DB00199 | approved; investigational; vet_approved | small molecule | Erythromycin | Indication associated | Details |
| R0085 | DB00218 | approved; investigational | small molecule | Moxifloxacin | Indication associated | Details |
| R0094 | DB00250 | approved; investigational | small molecule | Dapsone | Therapeutic strategy associated | Details |
| R0109 | DB00303 | approved; investigational | small molecule | Ertapenem | Indication associated | Details |
| R0131 | DB00365 | approved; investigational; withdrawn | small molecule | Grepafloxacin | Indication associated | Details |
| R0146 | DB00438 | approved | small molecule | Ceftazidime | Indication associated | Details |
| R0148 | DB00440 | approved; vet_approved | small molecule | Trimethoprim | Indication associated | Details |
| R0151 | DB00447 | approved; investigational; withdrawn | small molecule | Loracarbef | Indication associated | Details |
| R0158 | DB00467 | approved; investigational | small molecule | Enoxacin | Indication associated | Details |
| R0167 | DB00487 | approved | small molecule | Pefloxacin | Indication associated | Details |
| R0180 | DB00535 | approved | small molecule | Cefdinir | Indication associated | Details |
| R0181 | DB00537 | approved; investigational | small molecule | Ciprofloxacin | Indication associated | Details |
| R0192 | DB00560 | approved | small molecule | Tigecycline | Indication associated | Details |
| R0207 | DB00595 | approved; investigational; vet_approved | small molecule | Oxytetracycline | Indication associated | Details |
| R0210 | DB00601 | approved; investigational | small molecule | Linezolid | Indication associated | Details |
| R0217 | DB00618 | approved | small molecule | Demeclocycline | Indication associated | Details |
| R0219 | DB00620 | approved; vet_approved | small molecule | Triamcinolone | Therapeutic strategy associated | Details |
| R0222 | DB00626 | approved; vet_approved | small molecule | Bacitracin | Indication associated | Details |
| R0235 | DB00671 | approved; investigational | small molecule | Cefixime | Indication associated | Details |
| R0238 | DB00684 | approved; investigational | small molecule | Tobramycin | Indication associated | Details |
| R0259 | DB00738 | approved; investigational | small molecule | Pentamidine | Indication associated | Details |
| R0267 | DB00759 | approved; vet_approved | small molecule | Tetracycline | Indication associated | Details |
| R0268 | DB00760 | approved; investigational | small molecule | Meropenem | Indication associated | Details |
| R0296 | DB00827 | approved; investigational; withdrawn | small molecule | Cinoxacin | Indication associated | Details |
| R0297 | DB00828 | approved | small molecule | Fosfomycin | Therapeutic strategy associated | Details |
| R0299 | DB00833 | approved | small molecule | Cefaclor | Indication associated | Details |
| R0309 | DB00853 | approved; investigational | small molecule | Temozolomide | Therapeutic strategy associated | Details |
| R0344 | DB00954 | experimental | small molecule | Dirithromycin | Indication associated | Details |
| R0345 | DB00959 | approved; vet_approved | small molecule | Methylprednisolone | Therapeutic strategy associated | Details |
| R0351 | DB00976 | approved | small molecule | Telithromycin | Indication associated | Details |
| R0353 | DB00978 | approved; investigational | small molecule | Lomefloxacin | Indication associated | Details |
| R0364 | DB01004 | approved; investigational | small molecule | Ganciclovir | Indication associated | Details |
| R0370 | DB01015 | approved | small molecule | Sulfamethoxazole | Indication associated | Details |
| R0372 | DB01017 | approved; investigational | small molecule | Minocycline | Target associated | Details |
| R0383 | DB01044 | approved; investigational | small molecule | Gatifloxacin | Indication associated | Details |
| R0386 | DB01053 | approved; vet_approved | small molecule | Benzylpenicillin | Indication associated | Details |
| R0390 | DB01066 | approved; investigational | small molecule | Cefditoren | Indication associated | Details |
| R0395 | DB01082 | approved; vet_approved | small molecule | Streptomycin | Indication associated | Details |
| R0409 | DB01112 | approved | small molecule | Cefuroxime | Indication associated | Details |
| R0412 | DB01117 | approved | small molecule | Atovaquone | Indication associated | Details |
| R0422 | DB01140 | approved; vet_approved; withdrawn | small molecule | Cefadroxil | Indication associated | Details |
| R0426 | DB01150 | approved | small molecule | Cefprozil | Indication associated | Details |
| R0428 | DB01155 | approved; investigational | small molecule | Gemifloxacin | Indication associated | Details |
| R0430 | DB01157 | approved; investigational | small molecule | Trimetrexate | Indication associated | Details |
| R0434 | DB01172 | approved; investigational; vet_approved | small molecule | Kanamycin | Indication associated | Details |
| R0448 | DB01208 | approved; investigational; withdrawn | small molecule | Sparfloxacin | Indication associated | Details |
| R0450 | DB01212 | approved | small molecule | Ceftriaxone | Indication associated | Details |
| R0494 | DB01329 | approved; investigational | small molecule | Cefoperazone | Indication associated | Details |
| R0517 | DB01413 | approved; investigational | small molecule | Cefepime | Indication associated | Details |
| R0540 | DB01602 | approved; investigational | small molecule | Bacampicillin | Indication associated | Details |
| R0541 | DB01604 | approved | small molecule | Pivampicillin | Indication associated | Details |
| R0542 | DB01606 | approved | small molecule | Tazobactam | Indication associated | Details |
| R0646 | DB04918 | approved; investigational | small molecule | Ceftobiprole | Indication associated | Details |
| R0654 | DB04934 | investigational | small molecule | Rifalazil | Therapeutic strategy associated | Details |
| R0721 | DB05161 | investigational | small molecule | Elafin | Therapeutic strategy associated | Details |
| R0742 | DB05222 | investigational | biotech | KB001 | Therapeutic strategy associated | Details |
| R0882 | DB05839 | investigational | small molecule | BG-777 | Indication associated | Details |
| R0991 | DB06358 | investigational | small molecule | Iclaprim | Indication associated | Details |
| R1003 | DB06402 | approved | small molecule | Telavancin | Indication associated | Details |
| R1014 | DB06437 | investigational | small molecule | Tifacogin | Indication associated | Details |
| R1040 | DB06532 | investigational | small molecule | Pafuramidine | Indication associated | Details |
| R1044 | DB06546 | investigational | biotech | Atibuclimab | Therapeutic strategy associated | Details |
| R1054 | DB06600 | investigational | small molecule | Nemonoxacin | Indication associated | Details |
| R1093 | DB06771 | approved | small molecule | Besifloxacin | Indication associated | Details |
| R1181 | DB08895 | approved; investigational | small molecule | Tofacitinib | Therapeutic strategy associated | Details |
| R1202 | DB09050 | approved; investigational | small molecule | Ceftolozane | Indication associated | Details |
| R1207 | DB09060 | approved | small molecule | Avibactam | Indication associated | Details |
| R1234 | DB09140 | approved; vet_approved | small molecule | Oxygen | Therapeutic strategy associated | Details |
| R1298 | DB09320 | approved; vet_approved | small molecule | Procaine benzylpenicillin | Indication associated | Details |
| R1299 | DB09324 | approved | small molecule | Sulbactam | Indication associated | Details |
| R1321 | DB10552 | approved | biotech | Peach | Indication associated | Details |
| R1421 | DB11943 | approved; investigational | small molecule | Delafloxacin | Indication associated | Details |
| R1432 | DB12107 | approved; investigational | small molecule | Vaborbactam | Indication associated | Details |
| R1448 | DB12455 | approved; investigational | small molecule | Omadacycline | Indication associated | Details |
| R1464 | DB12825 | approved; investigational | small molecule | Lefamulin | Indication associated | Details |
| R1480 | DB13163 | approved; experimental | small molecule | Terpin hydrate | Indication associated | Details |
| R1507 | DB13975 | experimental | biotech | Black cohosh | Therapeutic strategy associated | Details |
| R1592 | DB16365 | investigational | small molecule | Treamid | Therapeutic strategy associated | Details |
| R1595 | DB16398 | investigational | biotech | Efmarodocokin alfa | Therapeutic strategy associated | Details |
| R1598 | DB16448 | investigational | biotech | CD24Fc | Therapeutic strategy associated | Details |